publication date: Dec. 23, 2010

In this issue: 

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant.

Susan Sieber, Former NCI Communications Chief, Dead.

Andrew von Eschenbach Sworn In As NCI Director.

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

FDA Approves Abbott’s HER-2 DNA Probe Kit.

Univ. Of Pittsburgh Plans Molecular Medicine Institute.

Download (PDF 343KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.